The RealMoney contributors are in the business of trading and investing all day on the basis of ongoing news flow. Below, we offer the top five ideas that RealMoney contributors posted today and how they played those ideas.

brings you the news all day, and with


"Columnist Conversation," you can see how the pros are playing it on a real-time basis. Here are the top five ideas played today. To see all that



click here

for a free trial.

Powerful Breakout for Colgate

By Gary Morrow

2:20 p.m. EDT

Image placeholder title


(CL) - Get Colgate-Palmolive Company Report

is building on Friday's strong move with a 4% ramp. The stock finished off last week with a high-volume 3% surge that pushed the stock above its 200-day moving average for the first time since the October collapse.

Colgate is now trading just shy of its 2009 high of $69.70. I expect the stock to be at new highs this week.

Colgate has been on quite a run since bottoming in early March. The stock successfully tested its October lows of $54.35 back on March 9 before turning higher and with today's $2.75 gain, has recovered over half of the heavy loses suffered during the fall of last year.

The bulk of the gains have come during the last four weeks as extremely heavy upside volume returned. This leg of the run has left behind strong support in its wake. While I expect Colgate to easily take out its current 2009 highs, a healthy pullback would strengthen the trend.

I am not in the stock at this point but would be a buyer on a low-volume pullback. First layer of support is the double weekly highs left behind in late January and early February just below $67. Last week's high of $66 is also an area of support.

No positions.

Credit Cards Missing Out

By Alan Farley

12:31 p.m. EDT

Image placeholder title


(MA) - Get Mastercard Inc. (MA) Report



(V) - Get Visa Inc. Class A Report

are missing out on the first-of-month rally. The stocks are under pressure, with credit card reform legislation threatening to lower profits. In addition, there had been persistent rumors that one or both of these issues would be added to the Dow 30. That didn't happen, with


(TRV) - Get Travelers Companies, Inc. Report



(CSCO) - Get Cisco Systems, Inc. Report

getting the nod instead.

However, both issues have been fairly resilient, despite adverse news, so there's still a chance they'll move higher. Visa is the stronger play, filling out a broad triangle pattern, with resistance near 68. A breakout over that level could trigger a rally up to 77.

No positions.

Oil and Bonds

By Tim Melvin

11:55 a.m. EDT

I may have missed part of the stock rally in recent weeks, but some of my small long-term speculations are more than offsetting the pain. It is no secret that I never believed in this rally and still do not.

The market of course does not give a fig what I think and has staged one of the most impressive rallies in history. I would be more upset if I had not established small options bets early this year shorting treasuries and long oil. They are providing the type of asymmetrical payoff that more than compensates for my relatively light equity position.

These positions just made sense to me when I put them on and wrote about them earlier this year. The Saudi oil minister stated that he thought $75 was a fair price for oil. I think he will get his way by the end of the year and I will hold my

U.S. Oil Fund

(USO) - Get United States Oil Fund LP Report

calls until the January expiration.

In my mind, it is going to be impossible for bond prices to stay high in face of the massive issuance that will be needed this year. I do not think the selloff is done and will likewise hold my

iShares Barclays 20+ Treasury Bond

(TLT) - Get iShares 20+ Year Treasury Bond ETF Report

puts until expiration.

On counter-trend moves in either I will be willing to add a little to the positions.

Long USO calls; long TLT puts.

ASCO Trading

By Adam Feuerstein

TheStreet Recommends

10:23 a.m. EDT

Image placeholder title

Keryx Biopharmaceuticals

(KERX) - Get Keryx Biopharmaceuticals, Inc. Report

seems like the big winner so far, the only ASCO stock up significantly this morning. Also in the green but not much are








(IMMU) - Get Immunomedics, Inc. Report


Celdex Therapeutics

(CLDX) - Get Celldex Therapeutics, Inc. Report

doing a bit better, although I hear the Celdex spike may be on a rumor of a


report coming soon.

On the down side, there's


(IMGN) - Get ImmunoGen, Inc. Report




(the hottest pre-ASCO stock),





( OSIP).

No positions.

Airlines and Crude

By Bob Byrne

11:11 a.m. EDT

On Friday I posted that I was shorting crude and getting long airlines. I am taking off one-third of my airline long into today's ramp --





(UAL) - Get United Airlines Holdings, Inc. Report


US Airways


. I continue to hold

UltraShort DJ-AIG Crude Oil ProShares

(SCO) - Get ProShares UltraShort Bloomberg Crude Oil Report

, but it's more of a hedge against a basket of small energy longs than an actual bearish position on crude itself.

Long AMR, UAL, US Airways and SCO.

For a free trial to

Real Money

, where you can get updated trading and investment ideas throughout the course of the day, please click on the tile below.

Image placeholder title

This article was written by a staff member of